The discussion of cascade CIK cells treat a renal cell carcinoma with pulmonary metastasis patient
Cascade cytokine-Induced killer cells is a kind of new technology for tumor biological immunotherapy. Studies have found that renal cell carcinoma susceptibility to radiation and chemotherapy is not high. With the development of treatment technology, immune therapy as an important adjuvant treatmentsi of patients with advanced kidney cancer, to improve survival rate in patients with renal cell carcinoma. Recently, we treat one patient with stage Ⅳ renal cell carcinoma after immune therapy, his illness under control, and now to report this therapy for a discussion combined with literature.